EVALUATE THE EFFICACY OF PUNARNAVADI GUGGULU ORALY,TRIPHALA NIMBA KWATH YONI PRAKSHALANA AND JATYADI TAIL PICHU IN THE MANAGEMENT OF PARIPLUTA YONIVYAPADW.S.R. TO PID- A PILOT STUDY
Keywords:
Pariplutayonivyapad, Pelvic inflammatory diseases, miscarriage, yoni prakshalan, pichu.Abstract
Pariplutayonivyapad is common disorder seen in women of reproductive age group.It is one among the twenty ‘Yoni Vyapadas’ mentioned in the Ayurveda classics. Pariplutayonivyapad is due to vata- pitta dosha vitiation and is characterized by the complaint of excessive pain during coitus, abnormal vaginal discharge, generalized pain and feverish conditions. All the symptoms mimic the inflammatory conditions so it can be correlated to pelvic inflammatory diseases.In the National Health and Nutrition Examination Survey 2013–2014 cycle, the prevalence of a self-reported lifetime Pelvic Inflammatory diseases diagnosis was 4.4% among sexually experienced reproductive-aged women, equating to 2.5 million prevalent pelvic inflammatory disease cases in women aged 18–44 years nationwide. Prevalence of a self-reported lifetime pelvic inflammatory disease diagnosis varied by sexual behaviours and sexual health history and differed by race/ethnicity in women without a prior Sexually Transmitted Infection diagnosis. Pelvic inflammatory disease implies inflammation of the upper genital tract. A number of serious complications have been linked with delayed management of pelvic inflammatory diseases like miscarriage, chronic pelvic pain, Sexually Transmitted Diseases, progressive organ damage and infertility. The present pilot study was designed to evaluate the role of ‘Punarnavadi Guggulu’orally, ‘Triphla Nimba kwath’yoni prakshalan and ‘JatyadiTail pichu’ in paripluta yoni vyapad. Total 12 patients were enrolled and as study shows extremely significant results were found in treating almost all the major symptoms. The overall result shows maximum improvement in all the assessment parameters.
Downloads
Published
How to Cite
Issue
Section
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.